Arno Therapeutics, Inc.
ARNI · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $8 | $27 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $8 | $27 | $11 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $2 |
| Total NC Assets | $0 | $0 | $0 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $8 | $27 | $13 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $3 | $2 |
| Short-Term Debt | $2 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $2 |
| Total Curr. Liab. | $4 | $2 | $4 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $7 | $36 | $21 |
| Total NC Liab. | $5 | $7 | $36 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $9 | $40 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $4 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$93 | -$82 | -$90 | -$50 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $85 | $81 | $77 | $38 |
| Total Equity | -$9 | -$1 | -$13 | -$12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $8 | $27 | $13 |
| Net Debt | $2 | -$8 | -$27 | -$10 |